观察参麦注射液联合血塞通注射液治疗冠心病不稳定型心绞痛的临床疗效

Clinical effect of Shenmai injection combined with Xuesaitong injection on unstable angina pectoris of coronary heart disease

目的:观察参麦注射液联合血塞通注射液治疗冠心病不稳定型心绞痛的临床疗效。方法:收治冠心病不稳定型心绞痛患者41例,随机分为两组。观察组给予参麦注射液联合血塞通注射液治疗;对照组给予参麦注射液治疗。比较两组治疗效果。结果:观察组治疗总有效率、心绞痛发作频率及心肌缺血改善情况均优于对照组,差异有统计学意义(P<0.05)。结论:参麦注射液联合血塞通注射液治疗冠心病不稳定型心绞痛,临床疗效较高,可有效改善患者心肌缺血情况,减少心绞痛发作频率。

Objective:To explore the clinical effect of Shenmai injection combined with Xuesaitong Injection on unstable angina pectoris of coronary heart disease.Methods:41 patients with unstable angina pectoris of coronary heart disease were selected and randomly divided into two groups.The observation group was treated with Shenmai injection and Xuesaitong injection.The control group was treated with Shenmai injection.We compared the efficacy of the two groups.Results:In the observation group,the total effective rate,the frequency of angina attack and the improvement of myocardial ischemia were all better than those in the control group,the difference was statistically significant(P<0.05).Conclusion:The clinical effect of Shenmai injection combined with Xuesaitong Injection on unstable angina pectoris of coronary heart disease is high,it can effectively improve myocardial ischemia and reduce the frequency of angina attack.